CARCINOMA IN SITU
Clinical trials for CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New injection therapy targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug, ONM-501, injected directly into tumors, either alone or with another drug (cemiplimab), in people with advanced solid tumors or lymphomas that have not responded to other treatments. The main goals are to find the safest dose and understan…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE1 • Sponsor: OncoNano Medicine, Inc. • Aim: Disease control
Last updated May 26, 2026 05:25 UTC
-
New combo therapy aims to keep bladder cancer from coming back
Disease control Recruiting nowThis study tests whether adding an experimental drug (V940) to standard BCG immunotherapy can help people with high-risk non-muscle invasive bladder cancer live longer without their cancer returning or spreading. About 308 adults who have not had BCG before will be randomly assig…
Matched conditions: CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Massive childhood cancer registry aims to unlock better treatments
Knowledge-focused Recruiting nowThis study collects health information and leftover tumor or blood samples from children and young adults with cancer. The goal is to learn more about these diseases and find better ways to treat and care for patients over time. Up to 75,000 people will take part, and no experime…
Matched conditions: CARCINOMA IN SITU
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated May 26, 2026 05:26 UTC